Neuromuscular blocking effect of aminoglycoside antibiotics in nonhuman primates.
D000617:Aminoglycosides / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002122:Calcium Chloride / Q000008:administration & dosage / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000008:administration & dosage / Q000494:pharmacology; D005839:Gentamicins / Q000008:administration & dosage / Q000494:pharmacology; D000882:Haplorhini; D007275:Injections, Intravenous; D007612:Kanamycin / Q000008:administration & dosage / Q000494:pharmacology; D008251:Macaca; D009119:Muscle Contraction; D009132:Muscles / Q000187:drug effects; D009355:Neomycin / Q000008:administration & dosage / Q000494:pharmacology; D009388:Neostigmine / Q000008:administration & dosage / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010215:Papio; D012584:Sciatic Nerve / Q000187:drug effects; D013307:Streptomycin / Q000008:administration & dosage / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D009388:Neostigmine; D007612:Kanamycin; D009355:Neomycin; D002122:Calcium Chloride; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin